For people 9 years and older with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function

For people 9 years and older with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function

Explore the path of possibilities with Rivfloza®

Look forward to the journey ahead with a once-monthly treatment that lowers and keeps urinary oxalate levels under control.

Learn about Rivfloza®
Shield with checkmark icon

Find out how Rivfloza® helps prevent extra oxalate from being produced in people with PH1.

Learn more
House icon

The only selfa- or caregivera,b-administered PH1 treatment.

Learn how to take Rivfloza®

aAfter proper training by a health care professional for patients 12 years of age and up.

bFor children 9 to 11 years of age (after training and guidance from a health care professional for the single-dose vial).

 Hands holding icon

Our NovoCare® patient support team can provide more information about Rivfloza® and how to get started on treatment.

Get started
Father and daughter riding a bike

Stay in the know

If you would like to receive more information, including
the latest updates, on Rivfloza®, register today.

Sign up
Show more Show less

Important Safety Information

What are the possible side effects of Rivfloza®?

The most common side effects of Rivfloza® include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

What is Rivfloza®?

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza® is safe and effective in children younger than 9 years of age.

What is Rivfloza®?

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza® is safe and effective in children younger than 9 years of age.

Show more Show less
Show more Show less

What is Rivfloza®?

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza® is safe and effective in children younger than 9 years of age.

What is Rivfloza®?

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza® is safe and effective in children younger than 9 years of age.

Important Safety Information

What are the possible side effects of Rivfloza®?

The most common side effects of Rivfloza® include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

Important Safety Information

What are the possible side effects of Rivfloza®?

The most common side effects of Rivfloza® include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

Important Safety Information

What are the possible side effects of Rivfloza®?

The most common side effects of Rivfloza® include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

What is Rivfloza®?

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza® is safe and effective in children younger than 9 years of age.

What is Rivfloza®?

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza® is safe and effective in children younger than 9 years of age.

Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Rivfloza® is a registered trademark of Novo Nordisk Health Care AG.
NovoCare® and Novo Nordisk are registered trademarks of Novo Nordisk A/S.

 

© 2024 Novo Nordisk All rights reserved. US24RVZA00090 October 2024

You are about to leave Rivfloza.com, a Novo Nordisk website.

Click “Continue” to leave the site and come back to visit us another time. Click “Return to site” to stay and learn more about Rivfloza® (nedosiran) injection.

Continue

You are about to leave Rivfloza.com, a Novo Nordisk website

Click “Continue” to leave the site. Novo Nordisk is not responsible for the content on the site you are about to visit. Click “Return to site” to stay and learn more about Rivfloza® (nedosiran) injection.

Continue
Access Resources